BlueVoyant closes an expanded Series B on $82.5m

BlueVoyant, an analytics-driven cybersecurity company, has closed an expanded Series B round on $82.5m.

The funding was supplied by a selection of new and existing investors, including financial services technology provider Fiserv.

With the close of the round, BlueVoyant has raised a total of $207.5m in funding to date.

Funds from the round will be used to accelerate growth in the development of its cloud-based cybersecurity product platform. The cybersecurity startup also hopes to increase the growth across Europe and Asia by expanding its sales, engineering and security operations centre teams.

BlueVoyant is a data analytics-driven cybersecurity company which helps protect businesses of all sizes from cyberattacks. It offers advanced threat intelligence, managed security services and professional services.

New York-based, the startup empowers companies to monitor their external attack surface, assess emerging risks and deliver near real-time, actionable insights.

The company launched its managed security services in June 2018 and since then it has seen its customer base increase to more than 150 clients from sectors including financial services, manufacturing, and government and education sectors.

BlueVoyant co-founder and CEO Jim Rosenthal said, “This latest round of funding will enable BlueVoyant to bring corporate cyber defense capabilities to global businesses of all sizes ranging from large businesses with advanced defenses to small-medium size enterprises. We were delighted to expand our Series B funding round to accommodate strong investor demand.”

Last year, BlueVoyant partnered with Fiserv to launch a cybersecurity platform with orchestrates an organisation’s internal cybersecurity modules and provides a customisable portal with skilled cyber experts.

Enjoyed the story? 

Subscribe to our weekly RegTech newsletter and get the latest industry news & research

Copyright © 2018 RegTech Analyst

Investors

The following investor(s) were tagged in this article.